Aster Capital Management (Difc) LTD Rocket Pharmaceuticals, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $462 Billion
- Q3 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 1,137 shares of RCKT stock, worth $17,816. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,137Holding current value
$17,816% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RCKT
# of Institutions
204Shares Held
93.2MCall Options Held
278KPut Options Held
30.1K-
Rtw Investments, LP New York, NY17.7MShares$277 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$176 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$97 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.54MShares$86.8 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.49MShares$70.4 Million0.39% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.19B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...